Volume 4 Issue 3
Jul.  2024
Turn off MathJax
Article Contents
Lina Xuan, Huishan Luo, Shu Wang, Guangze Wang, Xingmei Yang, Jun Chen, Jianjun Guo, Xiaomeng Duan, Xiufang Li, Hua Yang, Shengjie Wang, Hailong Zhang, Qingqing Zhang, Shulei Liu, Yongtao She, Kai Kang, Lihua Sun. Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction[J]. Frigid Zone Medicine, 2024, 4(3): 137-151. doi: 10.1515/fzm-2024-0015
Citation: Lina Xuan, Huishan Luo, Shu Wang, Guangze Wang, Xingmei Yang, Jun Chen, Jianjun Guo, Xiaomeng Duan, Xiufang Li, Hua Yang, Shengjie Wang, Hailong Zhang, Qingqing Zhang, Shulei Liu, Yongtao She, Kai Kang, Lihua Sun. Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction[J]. Frigid Zone Medicine, 2024, 4(3): 137-151. doi: 10.1515/fzm-2024-0015

Circulating CCRR serves as potential novel biomarker for predicting acute myocardial infarction

doi: 10.1515/fzm-2024-0015
Funds:

the Natural Science Foundation of China 81970202

the Natural Science Foundation of China 81903609

Natural Science Foundation of Heilongjiang Province, China LH2022H002

the Outstanding Young Talent Research Fund of College of Pharmacy, Harbin Medical University 2019-JQ-02

2021 (the second batch) Research Funds for affiliated research institutes in Heilongjiang Province CZKYF2021-2-C013

More Information
  • Corresponding author: Kai Kang, E-mail: kangkai1975@sina.com; Lihua Sun, E-mail: sunlihua0219@163.com
  • #These authors contributed equally to this work.

  • Received Date: 2024-04-01
  • Accepted Date: 2024-06-07
  • Available Online: 2024-07-01
  •   Objective   Cold regions exhibit a high prevalence of cardiovascular disease, particularly acute myocardial infarction (AMI), which is one of the leading causes of death associated with cardiovascular conditions. Cardiovascular disease is closely linked to the abnormal expression of long non-coding RNA (lncRNA). This study investigates whether circulating levels of lncRNA cardiac conduction regulatory RNA (CCRR) could serve as a biomarker for AMI.   Materials and methods   We measured circulating CCRR from whole blood samples collected from 68 AMI patients and 69 non-AMI subjects. An AMI model was established using C57BL/6 mice. Quantitative reverse transcription PCR (qRT-PCR) was used to assess CCRR expression. Exosomes were isolated from cardiomyocytes, and their characteristics were evaluated using electron microscope and nanoparticle tracking analysis. The exosome inhibitor GW4869 was employed to examine the effect of exosomal CCRR on cardiac function using echocardiography. Protein expression was detected using Western blot and immunofluorescence staining.   Results   The circulating level of CCRR was significantly higher in AMI patients (1.93 ± 0.13) than in nonAMI subjects (1.00 ± 0.05, P < 0.001). The area under the ROC curve (AUC) of circulating CCRR was 0.821. Similar changes in circulating CCRR levels were consistently observed in an AMI mouse model. Exosomal CCRR derived from hypoxia-induced cardiomyocytes and cardiac tissue after AMI were increased, a change that was reversed by GW4869. Additionally, CCRR-overexpressing exosomes improved cardiac function in AMI.   Conclusion   Circulating lncRNA CCRR is a potential predictor of AMI. Exosomal CCRR plays a role in the communication between the heart and other organs through circulation.

     

  • loading
  • [1]
    Roth G A, Mensah G A, Johnson C O, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J. Am. Coll. Cardiol, 2020; 76: 2982-3021.
    [2]
    Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiology, 2019; 4 (4): 342-352. doi: 10.1001/jamacardio.2019.0295
    [3]
    Zhao D. Epidemiological features of cardiovascular disease in Asia. JACC: Asia, 2021; 1 (1): 1-13. doi: 10.1016/j.jacasi.2021.04.007
    [4]
    Li X, Wu C, Lu J, et al. Cardiovascular risk factors in China: a nationwide population-based cohort study. The Lancet Public Health, 2020; 5 (12): e672-e681. doi: 10.1016/S2468-2667(20)30191-2
    [5]
    Lei J, Chen R, Yin P, et al. Association between cold spells and mortality risk and burden: a nationwide study in China. Environmental Health Perspectives, 2022; 130 (2): 027006. doi: 10.1289/EHP9284
    [6]
    Schulte C, Barwari T, Joshi A, et al. Noncoding RNAs versus protein biomarkers in cardiovascular disease. Trends Mol Med, 2020; 26: 583-596. doi: 10.1016/j.molmed.2020.02.001
    [7]
    Emdin M, Aimo A, Vergaro G, et al. sST2 predicts outcome in chronic heart failure beyond NT-proBNP and high-sensitivity troponin T. J Am Coll Cardiol, 2018; 72: 2309-2320. doi: 10.1016/j.jacc.2018.08.2165
    [8]
    Wang Y, Sun X. The functions of LncRNA in the heart. Diabetes Res Clin Pract, 2020; 168: 108249. doi: 10.1016/j.diabres.2020.108249
    [9]
    Mozaffarian D, Benjamin E J, Go A S, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation, 2015; 131: e29-322. doi: 10.1161/circ.131.suppl_2.o29
    [10]
    Kopp F, Mendell J T. Functional classification and experimental dissection of long noncoding RNAs. Cell, 2018; 172: 393-407. doi: 10.1016/j.cell.2018.01.011
    [11]
    Chang G, Zhang W, Zhang M, et al. Clinical value of circulating ZFAS1 and miR-590-3p in the diagnosis and prognosis of chronic heart failure. Cardiovasc. Toxicol, 2021; 21: 880-888. doi: 10.1007/s12012-021-09678-7
    [12]
    Sharma S, Findlay G M, Bandukwala H S, et al. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA protein scaffold complex. Proc Natl Acad Sc, 2011; 108: 11381-11386. doi: 10.1073/pnas.1019711108
    [13]
    Viereck J, Thum T. Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ Res, 2017; 120: 381-399. doi: 10.1161/CIRCRESAHA.116.308434
    [14]
    Cao M, Luo H, Li D, et al. Research advances on circulating long noncoding RNAs as biomarkers of cardiovascular diseases. Int J Cardiol, 2022; 353: 109-117. doi: 10.1016/j.ijcard.2022.01.070
    [15]
    Zhang Y, Sun L, Xuan L, et al. Reciprocal changes of circulating long non-coding RNAs ZFAS1 and CDR1AS predict acute myocardial infarction. Sci Rep, 2016; 6: 2384.
    [16]
    Wang X, Wang L, Ma Z, et al. Early expressed circulating long noncoding RNA CHAST is associated with cardiac contractile function in patients with acute myocardial infarction. Int J Cardiol, 2020; 302: 15-20. doi: 10.1016/j.ijcard.2019.12.058
    [17]
    Tang Y, Zheng J, Sun Y, et al. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J, 2009; 50: 377-387. doi: 10.1536/ihj.50.377
    [18]
    Gao L, Liu Y, Guo S, et al. Circulating long noncoding RNA HOTAIR is an essential mediator of acute myocardial infarction. Cell. Physiol. Biochem, 2017; 44: 1497-1508. doi: 10.1159/000485588
    [19]
    Azat M, Huojiahemaiti X, Gao R, et al. Long noncoding RNA MIAT: a potential role in the diagnosis and mediation of acute myocardial infarction. Mol Med Rep, 2019; 20: 5216-5222.
    [20]
    Wang L, Wang L, Wang Q. Constitutive activation of the NEAT1/miR-22-3p/Ltb4r1 signaling pathway in mice with myocardial injury following acute myocardial infarction. Aging (Albany NY), 2021; 13: 15307-15319.
    [21]
    Li M, Wang Y F, Yang X C, et al. Circulating long noncoding RNA LIPCAR acts as a novel biomarker in patients with ST-segment elevation myocardial infarction. Med Sci Monit, 2018; 24: 5064-5070. doi: 10.12659/MSM.909348
    [22]
    Yan L, Zhang Y, Zhang W, et al. lncRNA-NRF is a potential biomarker of heart failure after acute myocardial infarction. J Cardiovasc Transl Res, 2020; 13: 1008-1015. doi: 10.1007/s12265-020-10029-0
    [23]
    Zhang Y, Sun L, Xuan L, et al. Long non-coding RNA CCRR controls cardiac conduction via regulating intercellular coupling. Nat Commun, 2018; 9: 4176. doi: 10.1038/s41467-018-06637-9
    [24]
    Khodayi M, Khalaj-Kondori M, Hoseinpour F M A, et al. Plasma lncRNA profiling identified BC200 and NEAT1 lncRNAs as potential blood-based biomarkers for late-onset Alzheimer's disease. EXCLI J, 2022; 21: 772-785.
    [25]
    Isaac R, Reis F C G, Ying W, et al. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab, 2021; 33: 1744-1762. doi: 10.1016/j.cmet.2021.08.006
    [26]
    Zheng M L, Liu X Y, Han R J, et al. Circulating exosomal long noncoding RNAs in patients with acute myocardial infarction. J Cell Mol Med, 2020; 24: 9388-9396. doi: 10.1111/jcmm.15589
    [27]
    Catalano M, O'Driscoll L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracell Vesicles, 2020; 9, 1703244. doi: 10.1080/20013078.2019.1703244
    [28]
    Crea F. How epidemiology can improve the understanding of cardiovascular disease: from mechanisms to treatment. Eur Heart J, 2021; 42: 4503-4507. doi: 10.1093/eurheartj/ehab797
    [29]
    Lerman B, Lerman L O. "Nothing burns like the cold": Cardiovascular disease in frigid zones. Frigid Zone Medicine, 2022; 2 (3): 129-131. doi: 10.2478/fzm-2022-0017
    [30]
    Jin H. Increased risk of cardiovascular disease in cold temperatures. Frigid Zone Medicine, 2022; 2 (3): 138-139. doi: 10.2478/fzm-2022-0020
    [31]
    Oitabén A, Fonseca P, Villanueva M J, et al. Emerging blood-based biomarkers for predicting immunotherapy response in NSCLC. Cancers (Basel), 2022; 14 (11), 2626. doi: 10.3390/cancers14112626
    [32]
    Chaitman B R, Cyr D D, Alexander K P, et al. Cardiovascular and renal implications of myocardial infarction in the ISCHEMIA-CKD trial. Circ Cardiovasc Interv, 2022; 15: e012103.
    [33]
    Wang F, Li X, Xie X, et al. UCA1, a non-protein-coding RNA upregulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett, 2008; 582: 1919-1927. doi: 10.1016/j.febslet.2008.05.012
    [34]
    Yan Y, Zhang B, Liu N, et al. Circulating long noncoding RNA UCA1 as a novel biomarker of acute myocardial infarction. Biomed Res Int, 2016; 2016: 8079372.
    [35]
    Zheng P F, Chen L Z, Liu P, et al. A novel lncRNA-miRNA-mRNA triple network identifies lncRNA XIST as a biomarker for acute myocardial infarction. Aging (Albany NY), 2022; 14: 4085-4106.
    [36]
    Wang Y, Zhao R, Liu W, et al. Exosomal circHIPK3 released from hypoxia-pretreated cardiomyocytes regulates oxidative damage in cardiac microvascular endothelial cells via the miR-29a/IGF-1 pathway. Oxid Med Cell Longev, 2019; 2019: 7954657.
    [37]
    Gupta S, Knowlton A A. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol, 2007; 292: H3052-3056.
    [38]
    King H W, Michael M Z, Gleadle J M. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer, 2021; 12: 421.
    [39]
    Vicencio J M, Yellon D M, Sivaraman V, et al. Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J Am Coll Cardiol, 2015; 65 (15): 1525-1536.
    [40]
    Tomasoni S, Longaretti L, Rota C, et al. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev, 2013; 22 (5): 772-778.
    [41]
    Jiao L, Li M, Shao Y, et al. lncRNA-ZFAS1 induces mitochondriamediated apoptosis by causing cytosolic Ca2+ overload in myocardial infarction mice model. Cell Death Dis, 2019; 10: 942.
    [42]
    Shao Y, Li M, Yu Q, et al. CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy. Eur J Pharmacol, 2022; 922: 174915.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(7)  / Tables(4)

    Article Metrics

    Article views (38) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return